Back to Search Start Over

Endosomal‐lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.

Authors :
Lai, Shereen Shi Min
Ng, Khuen Yen
Koh, Rhun Yian
Chok, Kian Chung
Chye, Soi Moi
Source :
Metabolic Brain Disease. Aug2021, Vol. 36 Issue 6, p1087-1100. 14p.
Publication Year :
2021

Abstract

The endosomal-lysosomal system mediates the process of protein degradation through endocytic pathway. This system consists of early endosomes, late endosomes, recycling endosomes and lysosomes. Each component in the endosomal-lysosomal system plays individual crucial role and they work concordantly to ensure protein degradation can be carried out functionally. Dysregulation in the endosomal-lysosomal system can contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). In AD endosomal-lysosomal abnormalities are the earliest pathological features to note and hence it is important to understand the involvement of endosomal-lysosomal dysfunction in the pathogenesis of AD. In-depth understanding of this dysfunction can allow development of new therapeutic intervention to prevent and treat AD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08857490
Volume :
36
Issue :
6
Database :
Academic Search Index
Journal :
Metabolic Brain Disease
Publication Type :
Academic Journal
Accession number :
151351456
Full Text :
https://doi.org/10.1007/s11011-021-00737-0